PAUL STEVEN M 4
4 · Rapport Therapeutics, Inc. · Filed Jun 18, 2025
Insider Transaction Report
Form 4
PAUL STEVEN M
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-06-17+21,850→ 21,850 totalExercise: $10.95Exp: 2035-06-17→ Common Stock (21,850 underlying)
Footnotes (1)
- [F1]The shares underlying this option shall vest upon the earlier of (i) June 17, 2026 and (ii) the date of the next Annual Meeting of Stockholders of the Issuer, subject to the Reporting Person's continued service on such vesting date.